{"podcast":{"title":"Health News Today | 2 Min News | The Daily News Now!","slug":"health-news-today-2-min-news-the-daily-news-now-7685759","podcast_index_feed_id":7685759,"rss_url":"https://feeds.fastcast.ai/health-and-fitness-news-today-2-min-news-the-daily-news-now.xml","website_url":null,"image_url":"https://image.fastcast.ai/cover/01017222-be18-4060-a2b6-ae821dbc23fa.png","author":"The Daily News Now!","episode_count":217,"summary":"Hosted by Corey with the Story, Health and Fitness News Today delivers fast, focused daily updates on the stories shaping health, wellness, and performance—from fitness trends and nutrition to medical breakthroughs and lifestyle insights. Designed for quick, on-the-go listening, each episode brings you up to speed in minutes. Produced by AI for speed, consistency, and global scale, the show is part of The Daily News Now network—covering the topics that impact your everyday life and keeping you informed. Health and Fitness News Today is your daily snapshot of what’s happening in health and wellness. Advertise on DNN: advertise@thednn.ai","last_synced_at":"2026-07-21T08:17:32.011297+00:00","page_url":"https://stenobird.com/podcast/health-news-today-2-min-news-the-daily-news-now-7685759"},"episode":{"title":"Genetic Clues to Targeted CLL Treatments | Health and Fitness News","slug":"genetic-clues-to-targeted-cll-treatments-health-and-fitness-news","published_at":"2026-07-10T14:10:47+00:00","page_url":"https://stenobird.com/podcast/health-news-today-2-min-news-the-daily-news-now-7685759/genetic-clues-to-targeted-cll-treatments-health-and-fitness-news","show_page_url":"https://stenobird.com/podcast/health-news-today-2-min-news-the-daily-news-now-7685759","url":"https://sources.thednn.ai/0b0908a0516871f4","audio_url":"https://api.fastcast.ai/audio/8b2baaef-d7c6-4725-9038-61e67cb91239.mp3","summary":"When treating chronic lymphocytic leukemia, doctors don’t just rely on the diagnosis—they decode the cancer’s genetic blueprint to predict behavior and tailor treatments. Key biomarkers like IGHV mutation status, chromosome abnormalities, and TP53 mutations reveal whether the cancer is slow or aggressive, guiding decisions toward targeted therapies like BTK inhibitors or venetoclax instead of outdated chemo. Since CLL’s genetics can evolve over time, these tests are repeated at diagnosis and before treatment to ensure the plan stays precise and effective. Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN: advertise@thednn.ai This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai. View sources & latest updates: https://sources.thednn.ai/0b0908a0516871f4","meta_description":"When treating chronic lymphocytic leukemia, doctors don’t just rely on the diagnosis—they decode the cancer’s genetic blueprint to predict behavior and ta…","key_points":[],"chapters":[],"topics":[],"duration_seconds":123,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/health-news-today-2-min-news-the-daily-news-now-7685759/episodes/genetic-clues-to-targeted-cll-treatments-health-and-fitness-news/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/health-news-today-2-min-news-the-daily-news-now-7685759/genetic-clues-to-targeted-cll-treatments-health-and-fitness-news.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}